Focusing national institutes of health HIV/AIDS research for maximum population impact

Rochelle P. Walensky, Charles J. Carpenter, Judith D. Auerbach, Moisés Agosto-Rosario, Dawn Averitt, John G. Bartlett, James W. Curran, Ralph DiClemente, Wafaa El-Sadr, Ashley Haase, Sharon Hillier, King K. Holmes, Paul A. Volberding

Research output: Contribution to journalReview article

Abstract

Progress in advancing research on the pathophysiology, prevention, treatment, and impact of human immunodeficiency virus (HIV) is threatened by the decaying purchasing power of National Institutes of Health (NIH) dollars. A working group of the NIH Office of AIDS Research Advisory Council was charged by the NIH Director with developing a focused and concise blueprint to guide the use of limited funding over the next few years. Science priorities outlined by the working group and reported here are intended to maximally address individuals, groups, and settings most affected by the epidemic, and to redress shortcomings in realizing population- level HIV prevention, treatment, and eradication goals. Optimizing these priorities requires that traditional silos-defined by topic focus and by scientific discipline-be dissolved and that structural issues affecting the pipeline of new investigators and the ability of the Office of AIDS Research to fulfill its role of steward of the NIH HIV/AIDS research program be directly addressed.

Original languageEnglish (US)
Pages (from-to)937-940
Number of pages4
JournalClinical Infectious Diseases
Volume60
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

National Institutes of Health (U.S.)
Acquired Immunodeficiency Syndrome
HIV
Research
Population
Research Personnel

Keywords

  • AIDS
  • HIV
  • National Institutes of Health (NIH)
  • Research

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Walensky, R. P., Carpenter, C. J., Auerbach, J. D., Agosto-Rosario, M., Averitt, D., Bartlett, J. G., ... Volberding, P. A. (2015). Focusing national institutes of health HIV/AIDS research for maximum population impact. Clinical Infectious Diseases, 60(6), 937-940. https://doi.org/10.1093/cid/ciu942

Focusing national institutes of health HIV/AIDS research for maximum population impact. / Walensky, Rochelle P.; Carpenter, Charles J.; Auerbach, Judith D.; Agosto-Rosario, Moisés; Averitt, Dawn; Bartlett, John G.; Curran, James W.; DiClemente, Ralph; El-Sadr, Wafaa; Haase, Ashley; Hillier, Sharon; Holmes, King K.; Volberding, Paul A.

In: Clinical Infectious Diseases, Vol. 60, No. 6, 01.01.2015, p. 937-940.

Research output: Contribution to journalReview article

Walensky, RP, Carpenter, CJ, Auerbach, JD, Agosto-Rosario, M, Averitt, D, Bartlett, JG, Curran, JW, DiClemente, R, El-Sadr, W, Haase, A, Hillier, S, Holmes, KK & Volberding, PA 2015, 'Focusing national institutes of health HIV/AIDS research for maximum population impact', Clinical Infectious Diseases, vol. 60, no. 6, pp. 937-940. https://doi.org/10.1093/cid/ciu942
Walensky RP, Carpenter CJ, Auerbach JD, Agosto-Rosario M, Averitt D, Bartlett JG et al. Focusing national institutes of health HIV/AIDS research for maximum population impact. Clinical Infectious Diseases. 2015 Jan 1;60(6):937-940. https://doi.org/10.1093/cid/ciu942
Walensky, Rochelle P. ; Carpenter, Charles J. ; Auerbach, Judith D. ; Agosto-Rosario, Moisés ; Averitt, Dawn ; Bartlett, John G. ; Curran, James W. ; DiClemente, Ralph ; El-Sadr, Wafaa ; Haase, Ashley ; Hillier, Sharon ; Holmes, King K. ; Volberding, Paul A. / Focusing national institutes of health HIV/AIDS research for maximum population impact. In: Clinical Infectious Diseases. 2015 ; Vol. 60, No. 6. pp. 937-940.
@article{47abe5deeacd4b48ad514f95a994c229,
title = "Focusing national institutes of health HIV/AIDS research for maximum population impact",
abstract = "Progress in advancing research on the pathophysiology, prevention, treatment, and impact of human immunodeficiency virus (HIV) is threatened by the decaying purchasing power of National Institutes of Health (NIH) dollars. A working group of the NIH Office of AIDS Research Advisory Council was charged by the NIH Director with developing a focused and concise blueprint to guide the use of limited funding over the next few years. Science priorities outlined by the working group and reported here are intended to maximally address individuals, groups, and settings most affected by the epidemic, and to redress shortcomings in realizing population- level HIV prevention, treatment, and eradication goals. Optimizing these priorities requires that traditional silos-defined by topic focus and by scientific discipline-be dissolved and that structural issues affecting the pipeline of new investigators and the ability of the Office of AIDS Research to fulfill its role of steward of the NIH HIV/AIDS research program be directly addressed.",
keywords = "AIDS, HIV, National Institutes of Health (NIH), Research",
author = "Walensky, {Rochelle P.} and Carpenter, {Charles J.} and Auerbach, {Judith D.} and Mois{\'e}s Agosto-Rosario and Dawn Averitt and Bartlett, {John G.} and Curran, {James W.} and Ralph DiClemente and Wafaa El-Sadr and Ashley Haase and Sharon Hillier and Holmes, {King K.} and Volberding, {Paul A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1093/cid/ciu942",
language = "English (US)",
volume = "60",
pages = "937--940",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Focusing national institutes of health HIV/AIDS research for maximum population impact

AU - Walensky, Rochelle P.

AU - Carpenter, Charles J.

AU - Auerbach, Judith D.

AU - Agosto-Rosario, Moisés

AU - Averitt, Dawn

AU - Bartlett, John G.

AU - Curran, James W.

AU - DiClemente, Ralph

AU - El-Sadr, Wafaa

AU - Haase, Ashley

AU - Hillier, Sharon

AU - Holmes, King K.

AU - Volberding, Paul A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Progress in advancing research on the pathophysiology, prevention, treatment, and impact of human immunodeficiency virus (HIV) is threatened by the decaying purchasing power of National Institutes of Health (NIH) dollars. A working group of the NIH Office of AIDS Research Advisory Council was charged by the NIH Director with developing a focused and concise blueprint to guide the use of limited funding over the next few years. Science priorities outlined by the working group and reported here are intended to maximally address individuals, groups, and settings most affected by the epidemic, and to redress shortcomings in realizing population- level HIV prevention, treatment, and eradication goals. Optimizing these priorities requires that traditional silos-defined by topic focus and by scientific discipline-be dissolved and that structural issues affecting the pipeline of new investigators and the ability of the Office of AIDS Research to fulfill its role of steward of the NIH HIV/AIDS research program be directly addressed.

AB - Progress in advancing research on the pathophysiology, prevention, treatment, and impact of human immunodeficiency virus (HIV) is threatened by the decaying purchasing power of National Institutes of Health (NIH) dollars. A working group of the NIH Office of AIDS Research Advisory Council was charged by the NIH Director with developing a focused and concise blueprint to guide the use of limited funding over the next few years. Science priorities outlined by the working group and reported here are intended to maximally address individuals, groups, and settings most affected by the epidemic, and to redress shortcomings in realizing population- level HIV prevention, treatment, and eradication goals. Optimizing these priorities requires that traditional silos-defined by topic focus and by scientific discipline-be dissolved and that structural issues affecting the pipeline of new investigators and the ability of the Office of AIDS Research to fulfill its role of steward of the NIH HIV/AIDS research program be directly addressed.

KW - AIDS

KW - HIV

KW - National Institutes of Health (NIH)

KW - Research

UR - http://www.scopus.com/inward/record.url?scp=84936123769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936123769&partnerID=8YFLogxK

U2 - 10.1093/cid/ciu942

DO - 10.1093/cid/ciu942

M3 - Review article

C2 - 25422391

AN - SCOPUS:84936123769

VL - 60

SP - 937

EP - 940

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 6

ER -